Top Markets
Coin of the day
Atrion Corporation Atrion Corporation

Atrion Corporation

ATRI
Rang in Aktien #38752
Atrion Corporation, along with its affiliated entities, specializes in the... Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.
Aktienkurs
$0.45992
Zuletzt synchronisiert: 2024-08-30
Marktkapitalisierung
$821.42K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Atrion Corporation (ATRI)

Kategorie

Gewinn für Atrion Corporation (ATRI)
Gewinn im Jun 2024 TTM: $14.38M
Laut den aktuellen Finanzberichten von Atrion Corporation betragen die aktuellen Gewinne des Unternehmens $14.38M. Im Jahr 2022 erzielte das Unternehmen einen Gewinn von $40.62M, eine Steigerung gegenüber dem Gewinn im Jahr 2021, der $38.43M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Atrion Corporation von 2000 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $14.38M -35.75%
2023 $22.38M -44.91%
2022 $40.62M 5.69%
2021 $38.43M -0.10%
2020 $38.47M -10.89%
2019 $43.17M 2.69%
2018 $42.04M -0.72%
2017 $42.34M 7.83%
2016 $39.27M -3.92%
2015 $40.87M -2.74%
2014 $42.02M 7.02%
2013 $39.27M 11.95%
2012 $35.08M -11.15%
2011 $39.48M 23.41%
2010 $31.99M 25.03%
2009 $25.58M 9.98%
2008 $23.26M 16.31%
2007 $20.00M 41.13%
2006 $14.17M -88.83%
2005 $126.85M 1,376.08%
2004 $8.59M 57.17%
2002 $5.47M -9.84%
2001 $6.07M 69.13%
2000 $3.59M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$3.81B 26,373.29%
US
$4.11B 28,481.26%
FR
- -
JP
$1.59B 10,960.10%
US
- -
CH